RIGL

Latest SEC Filings & News for RIGL

1 most recent filing and news item mentioning RIGL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/RIGL/news?limit=20"

Pull RIGL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
Earnings|Offering|M&AAug 4, 2026Positive

Rigel Reports Q2 2026 Financial Results and In-Licenses VEPPELLEC

Rigel Pharmaceuticals reported $78.7 million in Q2 2026 revenues and $17.3 million in net income. The company advanced its commercial portfolio by in-licensing the PROTAC vepdegestrant from Arvinas.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.